These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

582 related items for PubMed ID: 28457675

  • 1. Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy.
    Wichgers Schreur PJ, van Keulen L, Kant J, Kortekaas J.
    Vaccine; 2017 May 25; 35(23):3123-3128. PubMed ID: 28457675
    [Abstract] [Full Text] [Related]

  • 2. Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination.
    Wichgers Schreur PJ, Kant J, van Keulen L, Moormann RJ, Kortekaas J.
    Vaccine; 2015 Mar 17; 33(12):1459-64. PubMed ID: 25665959
    [Abstract] [Full Text] [Related]

  • 3. Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep.
    Bird BH, Maartens LH, Campbell S, Erasmus BJ, Erickson BR, Dodd KA, Spiropoulou CF, Cannon D, Drew CP, Knust B, McElroy AK, Khristova ML, Albariño CG, Nichol ST.
    J Virol; 2011 Dec 17; 85(24):12901-9. PubMed ID: 21976656
    [Abstract] [Full Text] [Related]

  • 4. An equine herpesvirus type 1 (EHV-1) vector expressing Rift Valley fever virus (RVFV) Gn and Gc induces neutralizing antibodies in sheep.
    Said A, Elmanzalawy M, Ma G, Damiani AM, Osterrieder N.
    Virol J; 2017 Aug 14; 14(1):154. PubMed ID: 28807043
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep.
    Weingartl HM, Nfon CK, Zhang S, Marszal P, Wilson WC, Morrill JC, Bettinger GE, Peters CJ.
    Vaccine; 2014 Apr 25; 32(20):2345-9. PubMed ID: 24462482
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of three candidate Rift Valley fever vaccines in sheep.
    Kortekaas J, Antonis AF, Kant J, Vloet RP, Vogel A, Oreshkova N, de Boer SM, Bosch BJ, Moormann RJ.
    Vaccine; 2012 May 14; 30(23):3423-9. PubMed ID: 22449427
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the Efficacy, Potential for Vector Transmission, and Duration of Immunity of MP-12, an Attenuated Rift Valley Fever Virus Vaccine Candidate, in Sheep.
    Miller MM, Bennett KE, Drolet BS, Lindsay R, Mecham JO, Reeves WK, Weingartl HM, Wilson WC.
    Clin Vaccine Immunol; 2015 Aug 14; 22(8):930-7. PubMed ID: 26041042
    [Abstract] [Full Text] [Related]

  • 8. Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep.
    Morrill JC, Carpenter L, Taylor D, Ramsburg HH, Quance J, Peters CJ.
    Vaccine; 1991 Jan 14; 9(1):35-41. PubMed ID: 2008798
    [Abstract] [Full Text] [Related]

  • 9. A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection.
    López-Gil E, Lorenzo G, Hevia E, Borrego B, Eiden M, Groschup M, Gilbert SC, Brun A.
    PLoS Negl Trop Dis; 2013 Jan 14; 7(7):e2309. PubMed ID: 23875044
    [Abstract] [Full Text] [Related]

  • 10. Comparative efficacy of two next-generation Rift Valley fever vaccines.
    Kortekaas J, Oreshkova N, van Keulen L, Kant J, Bosch BJ, Bouloy M, Moulin V, Goovaerts D, Moormann RJ.
    Vaccine; 2014 Sep 03; 32(39):4901-8. PubMed ID: 25050973
    [Abstract] [Full Text] [Related]

  • 11. Immune correlates of protection of the four-segmented Rift Valley fever virus candidate vaccine in mice.
    Prajeeth CK, Zdora I, Saletti G, Friese J, Gerlach T, Wilken L, Beicht J, Kubinski M, Puff C, Baumgärtner W, Kortekaas J, Wichgers Schreur PJ, Osterhaus ADME, Rimmelzwaan GF.
    Emerg Microbes Infect; 2024 Dec 03; 13(1):2373313. PubMed ID: 38946528
    [Abstract] [Full Text] [Related]

  • 12. Rift Valley Fever Vaccine Virus Clone 13 Is Able to Cross the Ovine Placental Barrier Associated with Foetal Infections, Malformations, and Stillbirths.
    Makoschey B, van Kilsdonk E, Hubers WR, Vrijenhoek MP, Smit M, Wichgers Schreur PJ, Kortekaas J, Moulin V.
    PLoS Negl Trop Dis; 2016 Mar 03; 10(3):e0004550. PubMed ID: 27031621
    [Abstract] [Full Text] [Related]

  • 13. Creation of Rift Valley fever viruses with four-segmented genomes reveals flexibility in bunyavirus genome packaging.
    Wichgers Schreur PJ, Oreshkova N, Moormann RJ, Kortekaas J.
    J Virol; 2014 Sep 03; 88(18):10883-93. PubMed ID: 25008937
    [Abstract] [Full Text] [Related]

  • 14. Development of a novel, single-cycle replicable rift valley Fever vaccine.
    Murakami S, Terasaki K, Ramirez SI, Morrill JC, Makino S.
    PLoS Negl Trop Dis; 2014 Mar 03; 8(3):e2746. PubMed ID: 24651859
    [Abstract] [Full Text] [Related]

  • 15. Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes.
    Morrill JC, Jennings GB, Caplen H, Turell MJ, Johnson AJ, Peters CJ.
    Am J Vet Res; 1987 Jul 03; 48(7):1042-7. PubMed ID: 3631685
    [Abstract] [Full Text] [Related]

  • 16. Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates.
    Smith DR, Johnston SC, Piper A, Botto M, Donnelly G, Shamblin J, Albariño CG, Hensley LE, Schmaljohn C, Nichol ST, Bird BH.
    PLoS Negl Trop Dis; 2018 May 03; 12(5):e0006474. PubMed ID: 29742102
    [Abstract] [Full Text] [Related]

  • 17. Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle.
    Morrill JC, Mebus CA, Peters CJ.
    Am J Vet Res; 1997 Oct 03; 58(10):1104-9. PubMed ID: 9328662
    [Abstract] [Full Text] [Related]

  • 18. Protection of sheep against Rift Valley fever virus and sheep poxvirus with a recombinant capripoxvirus vaccine.
    Soi RK, Rurangirwa FR, McGuire TC, Rwambo PM, DeMartini JC, Crawford TB.
    Clin Vaccine Immunol; 2010 Dec 03; 17(12):1842-9. PubMed ID: 20876822
    [Abstract] [Full Text] [Related]

  • 19. Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs.
    Busquets N, Lorenzo G, López-Gil E, Rivas R, Solanes D, Galindo-Cardiel I, Abad FX, Rodríguez F, Bensaid A, Warimwe G, Gilbert SC, Domingo M, Brun A.
    Antiviral Res; 2014 Aug 03; 108():165-72. PubMed ID: 24933081
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep.
    Dungu B, Louw I, Lubisi A, Hunter P, von Teichman BF, Bouloy M.
    Vaccine; 2010 Jun 23; 28(29):4581-7. PubMed ID: 20470792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.